Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karuna Therapeutics (KRTX)
NASDAQ:KRTX
Holding KRTX?
Track your performance easily
See the Price Targets and Ratings of:
KRTX Analyst Ratings
Hold
0 Buy
15 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KRTX Stock 12 Month Forecast
Average Price Target
$330.00
▲(0.06% Upside)
| Highest Price Target$330.00 | Average Price Target$330.00 | Lowest Price Target$330.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
03/14/24
Mizuho Securities
Reiterated
03/01/24
JMP Securities
Reiterated
02/23/24
RBC Capital
Reiterated
02/22/24
J.P. Morgan
Downgraded
12/28/23
Maxim Group
Downgraded
12/26/23
Morgan Stanley
Downgraded
12/22/23
Wells Fargo
Downgraded
12/22/23
Guggenheim
Downgraded
12/22/23
Leerink Partners
$330
Hold
0.06%
Upside
Downgraded
12/22/23
Karuna Therapeutics downgraded to Market Perform from Outperform at LeerinkKaruna Therapeutics downgraded to Market Perform from Outperform at Leerink
William Blair
―
Hold
―
Downgraded
12/22/23
Karuna Therapeutics downgraded to Market Perform from Outperform at William BlairKaruna Therapeutics downgraded to Market Perform from Outperform at William Blair
Wedbush
$330
Hold
0.06%
Upside
Downgraded
12/22/23
Karuna Therapeutics downgraded to Neutral from Outperform at WedbushKaruna Therapeutics downgraded to Neutral from Outperform at Wedbush
Deutsche Bank
$330
Hold
0.06%
Upside
Downgraded
12/22/23
Analysts Offer Insights on Healthcare Companies: Clene (NASDAQ: CLNN) and Karuna Therapeutics (NASDAQ: KRTX)
Piper Sandler
$330
Hold
0.06%
Upside
Downgraded
12/22/23
Karuna Therapeutics downgraded to Neutral from Overweight at Piper SandlerKaruna Therapeutics downgraded to Neutral from Overweight at Piper Sandler
Best Analysts Covering Karuna Therapeutics
Which Analyst Should I Follow If I Want to Buy KRTX and Sell After:
1 Month
xxx
Success Rate
3/4 ratings generated profit
Average Return
+11.07%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +11.07% per trade.
3 Months
xxx
Success Rate
3/4 ratings generated profit
Average Return
+31.20%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +31.20% per trade.
1 Year
Success Rate
3/3 ratings generated profit
Average Return
+71.83%
reiterated a buy rating 2 years ago
Copying Esther Hong's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +71.83% per trade.
2 Years
xxx
Success Rate
3/3 ratings generated profit
Average Return
+141.53%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +141.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KRTX Analyst Recommendation Trends
Rating
Nov 23
Dec 23
Jan 24
Feb 24
Mar 24
Strong Buy
14
12
10
0
0
Buy
12
12
10
2
0
Hold
0
14
16
20
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
38
36
22
9
Each month's total comprises the sum of three months' worth of ratings.
KRTX Financial Forecast
KRTX Stock Forecast FAQ
What is KRTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Karuna Therapeutics’s 12-month average price target is $330.00.
What is KRTX’s upside potential, based on the analysts’ average price target?
Karuna Therapeutics has 0.06% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KRTX a Buy, Sell or Hold?
Karuna Therapeutics has a consensus rating of Hold which is based on 0 buy ratings, 15 hold ratings and 0 sell ratings.
What is Karuna Therapeutics’s price target?
The average price target for Karuna Therapeutics is $330.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $330.00 ,the lowest forecast is $330.00. The average price target represents 0.06% Increase from the current price of $329.79.
The highest analyst price target is $330.00 ,the lowest forecast is $330.00. The average price target represents 0.06% Increase from the current price of $329.79.
What do analysts say about Karuna Therapeutics?
Karuna Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of KRTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.